Generation of donor-specific immunotolerance in renal-allograft recipients
The kidney cannot be successfully grafted without immunosuppressive therapy. A unicenter retrospective study has evaluated the efficiency of immunosuppression with daclizumab (Zenapax) versus alemtuzumab (Campath).Subjects and methods. After renal allotransplantation, 64 patients, including 34 and 3...
Saved in:
| Main Authors: | V. A. Goryainov, M. M. Kaabak, M. M. Morozova, L. A. Shishlo, N. N. Babenko, A. K. Zokoyev |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2018-08-01
|
| Series: | Трансплантология (Москва) |
| Subjects: | |
| Online Access: | https://www.jtransplantologiya.ru/jour/article/view/240 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anemia in renal allograft recipients
by: V. A. Goryainov, et al.
Published: (2018-08-01) -
Use of Campath-1H in T-cell prolymphocytic leukemia (case report and review of literature)
by: V. A. Doronin, et al.
Published: (2022-11-01) -
The effect of the applied induction immunosuppressive therapy protocol on the allografted kidney condition
by: V. A. Goryaynov, et al.
Published: (2017-03-01) -
Combined use of Campath and total skin electron beam irradiation in mycosis fungoides
by: V. A. Doronin, et al.
Published: (2022-11-01) -
RELIEF OF HEPATITIS C WITH CYCLOSPORIN A IN THE ALLOGRAFTED KIDNEY RECIPIENT
by: V.A. Goryainov, et al.
Published: (2011-03-01)